Medical Problems During Pregnancy

  • Jose A. Arevalo
  • Thomas S. Nesbitt


All primary care physicians should have an understanding of the interaction of various medical conditions with pregnancy. Whereas only some primary care physicians provide primary obstetric care, nearly all family physicians care for women during their childbearing years. Medical conditions that coexist with pregnancy may profoundly affect the course of pregnancy, and pregnancy may have a significant effect on the course of certain medical conditions. In addition, many medical conditions decrease the patient’s chances of having a successful pregnancy if they are not diagnosed and addressed during the preconception period. For example, failure to adequately control a patient with insulin-dependent diabetes mellitus prior to conception may have disastrous consequences during the first few weeks of pregnancy, often before the patient seeks prenatal care. This chapter addresses conditions that may exist in pregnant patients. Limitation of space does not permit detailed discussion of each of these topics, but references are provided.


Immune Thrombocytopenic Purpura Chronic Hypertension Acute Pyelonephritis Asymptomatic Bacteriuria Congenital Toxoplasmosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Naeye RL. Causes of the excessive rates of perinatal mortality and prematurity in pregnancies complicated by maternal urinary-tract infection. N Engl J Med 1979;300:819–28.PubMedCrossRefGoogle Scholar
  2. 2.
    Harris RE. The significance of bacteriuria during pregnancy. Obstet Gynecol 1979;53:71–3.PubMedGoogle Scholar
  3. 3.
    Kass EH. The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: Quinn EL, Kass EH, editors. Biology of pyelonephritis. Boston: Little, Brown, 1960:399–412.Google Scholar
  4. 4.
    Whalley PJ. Bacteriuria of pregnancy. Am J Obstet Gynecol 1967;97:723–38.PubMedGoogle Scholar
  5. 5.
    Harris RE, Gilstrap LC. Cystitis during pregnancy: a distinct clinical entity. Obstet Gynecol 1981;57:578–80.PubMedGoogle Scholar
  6. 6.
    Jakobi P, Neigei R, Merzbach D, Paldi E. Single dose antimicrobial therapy in the treatment of asymptomatic bacteriuria in pregnancy. Am J Obstet Gynecol 1987;156:1148–52.PubMedGoogle Scholar
  7. 7.
    Duff P. Pyelonephritis in pregnancy. Clin Obstet Gynecol 1984;27:17–31.PubMedCrossRefGoogle Scholar
  8. 8.
    Kass EH. Pyelonephritis and bacteriuria: a major problem in preventive medicine. Ann Intern Med 1962;56:46–53.PubMedCrossRefGoogle Scholar
  9. 9.
    Fan YA, Pastorek JG, Miller JM, Mulvey J. Acute pyelonephritis in pregnancy. Am J Perinatol 1987;4:324–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Schuchat A, Swaminathan B, Broome CV. Epidemiology of human listeriosis. Clin Microbiol Rev 1991;4:169–83.PubMedGoogle Scholar
  11. 11.
    Beasley RP, Trepo C, Steven CE, Szmunsess W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977;105:94–8.PubMedGoogle Scholar
  12. 12.
    Westblom TU, Gudipati S, DeRousse C, Midkiff BR, Belshe RB. Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule. J Infect Dis 1994;169:996–1001.PubMedCrossRefGoogle Scholar
  13. 13.
    Nishioka K. Predominant mode of transmission of hepatitis B virus: perinatal transmission in Asia. In: Vyas GN, Dienstag JL, Hoofnagle IH, editors. Viral hepatitis and liver disease. Orlando, FL: Grune & Stratton, 1984:424–32.Google Scholar
  14. 14.
    Arevalo JA. Hepatitis B In pregnancy. West J Med 1989; 150:668–74.PubMedGoogle Scholar
  15. 15.
    Advisory Committee on Immunization Practices. Protection against viral hepatitis. MMWR 1990;39(suppl 2):1–26.Google Scholar
  16. 16.
    Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995;4:195–9.Google Scholar
  17. 17.
    Hoofnagle JH. Type D (delta) hepatitis. JAMA 1989;261: 1321–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Fox GN, Strangavity JW. Varicella-zoster virus infections in pregnancy. Am Fam Physician 1989;39:89–98.PubMedGoogle Scholar
  19. 19.
    Pastorek JG. Viral diseases. In: James DK, Steer PJ, Weiner CP, Gonik B, editors. High risk pregnancy: management options. 1st rev ed. London: Saunders, 1995:487–9.Google Scholar
  20. 20.
    Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United States. MMWR 1989; 38:1–25.Google Scholar
  21. 21.
    Cantwell MF, Snider DE, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272:535–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Centers for Disease Control. Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR 1990;38:1–12.Google Scholar
  23. 23.
    American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990;142:725–35.CrossRefGoogle Scholar
  24. 24.
    Bakht FR, Gentry LO. Toxoplasmosis in pregnancy: an emerging concern for family physicians. Am J Fam Pract 1992;45:1683–90.Google Scholar
  25. 25.
    Hammer GS, Hirshman SZ. Toxoplasmosis. In: Cherry SH, Merkatz IR, editors. Complications of pregnancy: medical, surgical, gynecologic, psychosocial, and perinatal, 4th rev ed. Baltimore: Williams & Wilkins, 1991:321–3.Google Scholar
  26. 26.
    Stepick-Biek P, Thulliez P, Araujo FG, Remington JS. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis 1990;162:270–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Remington JL, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn. 3rd rev ed. Philadelphia: Saunders, 1990:89–195.Google Scholar
  28. 28.
    Daffos F, Forestier F, Capella-Pavilosky M, et al. Prenatal management of management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988;318:271–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Danforth D. Other complications and disorders due to pregnancy. In: Danforth D, editor. Obstetrics and gynecology. 4th rev ed. Philadelphia: Harper & Row, 1982:482.Google Scholar
  30. 30.
    McFee JG. Iron metabolism and iron deficiency during pregnancy. Clin Obstet Gynecol 1979;22:799–812.PubMedCrossRefGoogle Scholar
  31. 31.
    Rutherford SE, Phelan JP. Deep venous thrombosis and pulmonary emboli in pregnancy. Crit Care Obstet 1991;18: 345–70.Google Scholar
  32. 32.
    Laros RK, Alger LS. Thromboembolism and pregnancy. Clin Obstet Gynecol 1979;22:871–88.PubMedCrossRefGoogle Scholar
  33. 33.
    Polak JF, Wilkinson DL. Ultrasonographic diagnosis of symptomatic deep venous thrombosis in pregnancy. Am J Obstet Gynecol 1991;165:625–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Spritizer CE, Evans AC, Kay HH. Magnetic resonance imaging of deep venous thrombosis in pregnant women with lower extremity edema. Obstet Gynecol 1995;85:603–7.CrossRefGoogle Scholar
  35. 35.
    Hull R, Delmore T, Carter C, et al. Adjusted subcutaneous heparin versus warfarin sodium in the long term treatment of venous thrombosis. N Engl J Med 1982;306:189.PubMedCrossRefGoogle Scholar
  36. 36.
    Demers C, Ginsberg JS. Deep venous thrombosis and pulmonary embolism in pregnancy. Clin Chest Med 1992;13: 642–56.Google Scholar
  37. 37.
    Ginsberg JS, Hirsh J, Turner DC, et al. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989;61:189–96.PubMedGoogle Scholar
  38. 38.
    Letsky EA, Warwick R. Hematologic problems. In: James DK, Steer PJ, Weiner CP, Gonik B, editors. High risk pregnancy: management options. 1st rev ed. London: Saunders, 1995:487–9.Google Scholar
  39. 39.
    Ballen TJ, Buskard N, Wittmann BK, et al. ITP in pregnancy: the use of bleeding time as an indicator for treatment. Blut 1989;59–132.Google Scholar
  40. 40.
    Christiaens GC, Heimerhorst FM. Validity of intrapartum diagnosis of fetal thrombocytopenia. Am J Obstet Gynecol 1987;157:864–5.PubMedGoogle Scholar
  41. 41.
    American Diabetes Association. Medical management of pregnancy complicated by diabetes. 2nd ed. Alexandria, VA: ADA, 1995.Google Scholar
  42. 42.
    Evans AT, Benbarka MM. Endocrine disorders. In: Niswander KR, editor. Manual of obstetrics. 3rd rev ed. Boston: Little, Brown, 1991:144–7.Google Scholar
  43. 43.
    Landon MB. Diabetes mellitus and other endocrine diseases. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 2nd rev ed. New York: Churchill Livingstone, 1991:1118.Google Scholar
  44. 44.
    McCarroll AM. The placental transfer of propylthiouracil, methimazol and carbamazepine. Arch Dis Child 1976;51–532.Google Scholar
  45. 45.
    Montoro M. Successful outcomes of pregnancy in women with hypothyroidism. Ann Intern Med 1981;94:31–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Collop NA, Harman EM. Pulmonary problems in pregnancy. Comp Ther 1990;16:17–23.Google Scholar
  47. 47.
    Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 3rd rev ed. Baltimore: Williams & Wilkins, 1990.Google Scholar
  48. 48.
    Huff RW. Asthma in pregnancy: medical problems in pregnancy. Med Clin North Am 1989;73:653–60.PubMedGoogle Scholar
  49. 49.
    Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Engl J Med 1992;326:927–31.PubMedCrossRefGoogle Scholar
  50. 50.
    Siba BM. Diagnosis and management of chronic hypertension in pregnancy. Obstet Gynecol 1991;78:451–61.Google Scholar
  51. 51.
    Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990;301:587–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Broughton-Pipkin F, Baker PN, Symonds EM. ACE inhibitors in pregnancy. Lancet 1989;2:96–7.Google Scholar
  53. 53.
    Michaletz-Onody PA. Peptic ulcer disease in pregnancy. Gastroenterol Clin North Am 1992;21:817–26.PubMedGoogle Scholar
  54. 54.
    Landon MB. Dermatologic disorders. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 2nd rev ed. New York: Churchill Livingstone, 1991:1215–21.Google Scholar
  55. 55.
    Habif TP. Clinical dermatology. 2nd rev ed. St. Louis: Mosby, 1990:660–4.Google Scholar
  56. 56.
    Samuels P. Neurologic complications. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 2nd rev ed. New York: Churchill Livingstone, 1991:1183–8.Google Scholar
  57. 57.
    Patterson RM. Seizure disorders in pregnancy. Med Clin North Am 1989;73:661–6.PubMedGoogle Scholar
  58. 58.
    Gjerde IO, Strandjord RE, Ulstein M. The course of epilepsy during pregnancy: a study of 18 cases. Acta Neurol Scand 1988;78–198.Google Scholar
  59. 59.
    Jones KL, Lacros RV, Johnson KA, Adama J. Pattern of malformations in children of women treated with carbamazepine. N Engl J Med 1989;320:1661–6.PubMedCrossRefGoogle Scholar
  60. 60.
    Collins SD. Neurologic complications. In: Niswander KR, editor. Manual of obstetrics: diagnosis and therapy. 4th rev ed. Boston: Little, Brown, 1991:187–191.Google Scholar
  61. 61.
    Uknis A, Siberstein SD. Review article: migraine and pregnancy. Headache 1991;31:372–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Jose A. Arevalo
  • Thomas S. Nesbitt

There are no affiliations available

Personalised recommendations